Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Tolerability and Efficacy of Erythropoietin (EPO) Treatment in Spinal Shock: Comparative Study VS Methylprednisolone (MP)

NCT00561067 is registered in ClinicalTrials.gov with Niguarda Hospital as lead sponsor.

NCT NCT00561067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00561067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Tolerability and Efficacy of Erythropoietin (EPO) Treatment in Spinal Shock: Comparative Study VS Methylprednisolone (MP)
Lead sponsor
Niguarda Hospital
Phase
Phase 3
Overall status
Terminated
Start date
April 30, 2008
Completion date
July 31, 2008
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spinal cord injury